Callitas Theraputics Inc., a wholly owned subsidiary of Callitas Health Inc.

Topical Menthol/L-arginine & Extrinsa

Topical Menthol/L-arginine & Extrinsa 2017-07-31T14:06:17+00:00

Project Description

< BACK TO OUR PATENTS

Currently used in ToConceive, a fertility enhancing moisturizer, and Extrinsa, a topical product to help women with orgasm and arousal difficulties.

US Patent 6,322,493: “Expanded clitoral sensitizing compounds with methods & apparatus for delivery”

US Patent 6,702,733: “Expanded clitoral sensitizing compounds with methods & apparatus for delivery”

US Patent 6,989,163: “Arrangement to enhance a woman’s sexual sensitivity by a combination of phytoestrogens, l-arginine, and menthol”

US Patent Application 15/047,960: “Topical Anorgasmia Therapy”

US Patent Application 15/050,732: “Menthol as Parabens Alternative”

US Patent Application 15/353/130: “In Vivo Sperm Selection for Male Infertility”

ABOUT CALLITAS

As a company, our number one goal is helping people by bringing products to market that improve quality of life. All our drug treatments and biomedical technologies fit our mission to deliver breakthrough products and services that reduce invasiveness and enhance daily living.

INVESTOR INQUIRIES

  • 1.859.868.3131
  • investors@callitas.com

  • 187 Pavilion Parkway
    Suite 200
    Newport, Kentucky 41071

PRESS AND MEDIA INQUIRIES

  • pressroom@callitas.com

PRODUCT INQUIRIES